These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
147 related articles for article (PubMed ID: 38046538)
1. The role of angiotensin receptor blocker (losartan) on decreasing fibrotic process of corpora cavernosa in priapism model of wistar rats. Siregar S; Rulianov R; Ksatriapraja RA; Stefanus D F1000Res; 2022; 11():831. PubMed ID: 38046538 [TBL] [Abstract][Full Text] [Related]
2. Losartan, an Angiotensin type I receptor, restores erectile function by downregulation of cavernous renin-angiotensin system in streptozocin-induced diabetic rats. Yang R; Yang B; Wen Y; Fang F; Cui S; Lin G; Sun Z; Wang R; Dai Y J Sex Med; 2009 Mar; 6(3):696-707. PubMed ID: 19175863 [TBL] [Abstract][Full Text] [Related]
3. Losartan treatment significantly attenuates the fibrotic changes in the corpus cavernosum of castrated rats. Kucukdurmaz F; Efe E; Kurutas EB; Olmez C; Temizer M; Resim S Rev Int Androl; 2020; 18(1):14-20. PubMed ID: 30245178 [TBL] [Abstract][Full Text] [Related]
4. Effect of Intracorporeal Human Adipose-Derived Stem Cells (hADSCs) on Corpora Cavernosa Transforming Growth Factor β Siregar S; Adriansjah R; Sibarani J; Mustafa A Res Rep Urol; 2020; 12():21-27. PubMed ID: 32104667 [TBL] [Abstract][Full Text] [Related]
5. Effect of combined farnesoid X receptor agonist and angiotensin II type 1 receptor blocker on ongoing hepatic fibrosis. Namisaki T; Kaji K; Shimozato N; Kaya D; Ozutsumi T; Tsuji Y; Fujinaga Y; Kitagawa K; Furukawa M; Sato S; Sawada Y; Nishimura N; Takaya H; Okura Y; Seki K; Kawaratani H; Moriya K; Noguchi R; Asada K; Akahane T; Mitoro A; Yoshiji H Indian J Gastroenterol; 2022 Apr; 41(2):169-180. PubMed ID: 35279807 [TBL] [Abstract][Full Text] [Related]
6. Angiotensin-receptor blocker losartan alleviates atrial fibrillation in rats by downregulating frizzled 8 and inhibiting the activation of WNT-5A pathway. Feng R; Wan J; He Y; Gong H; Xu Z; Feng J Clin Exp Pharmacol Physiol; 2023 Jan; 50(1):19-27. PubMed ID: 36047789 [TBL] [Abstract][Full Text] [Related]
7. Losartan Preserves Erectile Function by Suppression of Apoptosis and Fibrosis of Corpus Cavernosum and Corporal Veno-Occlusive Dysfunction in Diabetic Rats. Li WJ; Xu M; Gu M; Zheng DC; Guo J; Cai Z; Wang Z Cell Physiol Biochem; 2017; 42(1):333-345. PubMed ID: 28535536 [TBL] [Abstract][Full Text] [Related]
8. [Perindopril and losartan attenuate bleomycin A5-induced pulmonary fibrosis in rats]. Meng Y; Meng Y; Li X; Cai SX; Tong WC; Cheng YX Nan Fang Yi Ke Da Xue Xue Bao; 2008 Jun; 28(6):919-24. PubMed ID: 18583228 [TBL] [Abstract][Full Text] [Related]
9. Losartan preserves erectile function after bilateral cavernous nerve injury via antifibrotic mechanisms in male rats. Canguven O; Lagoda G; Sezen SF; Burnett AL J Urol; 2009 Jun; 181(6):2816-22. PubMed ID: 19375729 [TBL] [Abstract][Full Text] [Related]
10. Renin-angiotensin system blockade prevents the increase in plasma transforming growth factor beta 1, and reduces proteinuria and kidney hypertrophy in the streptozotocin-diabetic rat. Erman A; Veksler S; Gafter U; Boner G; Wittenberg C; van Dijk DJ J Renin Angiotensin Aldosterone Syst; 2004 Sep; 5(3):146-51. PubMed ID: 15526251 [TBL] [Abstract][Full Text] [Related]
11. Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities: a 24-week randomized controlled trial. Scaglione R; Argano C; Corrao S; Di Chiara T; Licata A; Licata G J Hypertens; 2005 Mar; 23(3):657-64. PubMed ID: 15716710 [TBL] [Abstract][Full Text] [Related]
12. Transforming growth factor beta1 mediates apoptotic activity of angiotensin II type I receptor blocker on prostate epithelium in vitro. Zhao Y; Peng J; Zheng L; Yu W; Jin J Prostate; 2010 Jun; 70(8):899-905. PubMed ID: 20135646 [TBL] [Abstract][Full Text] [Related]
13. Effects of angiotensin II subtype 1 receptor blockade by losartan on tubulointerstitial lesions caused by hyperoxaluria. Toblli JE; Ferder L; Stella I; De Cavanaugh EM; Angerosa M; Inserra F J Urol; 2002 Oct; 168(4 Pt 1):1550-5. PubMed ID: 12352456 [TBL] [Abstract][Full Text] [Related]
14. Increased adenosine contributes to penile fibrosis, a dangerous feature of priapism, via A2B adenosine receptor signaling. Wen J; Jiang X; Dai Y; Zhang Y; Tang Y; Sun H; Mi T; Phatarpekar PV; Kellems RE; Blackburn MR; Xia Y FASEB J; 2010 Mar; 24(3):740-9. PubMed ID: 19858092 [TBL] [Abstract][Full Text] [Related]
15. Combined therapy of cilazapril and losartan has no additive effects in ameliorating adriamycin-induced glomerulopathy. Kim HJ; Ryu JH; Han SW; Park IK; Paik SS; Park MH; Paik DJ; Chung HS; Kim SW; Lee JU Nephron Physiol; 2004; 97(4):p58-65. PubMed ID: 15331931 [TBL] [Abstract][Full Text] [Related]
16. Effect of losartan, an angiotensin II antagonist, on hepatic fibrosis induced by CCl4 in rats. Wei YH; Jun L; Qiang CJ Dig Dis Sci; 2004 Oct; 49(10):1589-94. PubMed ID: 15573910 [TBL] [Abstract][Full Text] [Related]
17. Two drugs with paradoxical effects on liver regeneration through antiangiogenesis and antifibrosis: Losartan and Spironolactone: a pharmacologic dilemma on hepatocyte proliferation. Parlakgumus A; Colakoglu T; Kayaselcuk F; Colakoglu S; Ezer A; Calıskan K; Karakaya J; Yildirim S J Surg Res; 2013 Jan; 179(1):60-5. PubMed ID: 22989552 [TBL] [Abstract][Full Text] [Related]
18. Structural analysis of the corpora cavernosa in patients with ischaemic priapism. Costa WS; Felix B; Cavalcanti AG; Medeiros J; Sampaio FJ BJU Int; 2010 Mar; 105(6):838-41; discussion 841. PubMed ID: 19751255 [TBL] [Abstract][Full Text] [Related]